» Articles » PMID: 35368685

Genetic Predispositions Between COVID-19 and Three Cardio-Cerebrovascular Diseases

Overview
Journal Front Genet
Date 2022 Apr 4
PMID 35368685
Authors
Affiliations
Soon will be listed here.
Abstract

: This study was aimed to apply a Mendelian randomization design to explore the causal association between coronavirus disease 2019 (COVID-19) and three cardio-cerebrovascular diseases, including atrial fibrillation, ischemic stroke, and coronary artery disease. : Two-sample Mendelian randomization was used to determine the following: 1) the causal effect of COVID-19 on atrial fibrillation (55,114 case participants vs 482,295 control participants), coronary artery disease (34,541 case participants vs 261,984 control participants), and ischemic stroke (34,217 case participants vs 40,611 control participants), which were obtained from the European Bioinformatics Institute, and 2) the causal effect of three cardio-cerebrovascular diseases on COVID-19. The single-nucleotide polymorphisms (SNPs) of COVID-19 were selected from the summary-level genome-wide association study data of COVID-19-hg genome-wide association study (GWAS) meta-analyses (round 5) based on the COVID-19 Host Genetics Initiative for participants with European ancestry. The random-effects inverse-variance weighted method was conducted for the main analyses, with a complementary analysis of the weighted median and Mendelian randomization (MR)-Egger approaches. : Genetically predicted hospitalized COVID-19 was suggestively associated with ischemic stroke, with an odds ratio (OR) of 1.049 [95% confidence interval (CI) 1.003-1.098;  = 0.037] in the COVID-19 Host Genetics Initiative GWAS. When excluding the UK Biobank (UKBB) data, our analysis revealed a similar odds ratio of 1.041 (95% CI 1.001-1.082;  = 0.044). Genetically predicted coronary artery disease was associated with critical COVID-19, with an OR of 0.860 (95% CI 0.760-0.973;  = 0.017) in the GWAS meta-analysis and an OR of 0.820 (95% CI 0.722-0.931;  = 0.002) when excluding the UKBB data, separately. Limited evidence of causal associations was observed between critical or hospitalized COVID-19 and other cardio-cerebrovascular diseases included in our study. : Our findings provide suggestive evidence about the causal association between hospitalized COVID-19 and an increased risk of ischemic stroke. Besides, other factors potentially contribute to the risk of coronary artery disease in patients with COVID-19, but not genetics.

Citing Articles

Association between chronic obstructive pulmonary disease and osteoporosis: Mendelian randomization combined with bibliometric analysis.

Yang F, Wang H, Liu M, Pei S, Qiu X Hereditas. 2025; 162(1):14.

PMID: 39893471 PMC: 11787750. DOI: 10.1186/s41065-025-00373-z.


Obstructive Sleep Apnea Syndrome and Obesity Indicators, Circulating Blood Lipid Levels, and Adipokines Levels: A Bidirectional Two-Sample Mendelian Randomization Study.

Zhang Y, Wang H, Yang J, Wang S, Tong W, Teng B Nat Sci Sleep. 2024; 16:573-583.

PMID: 38827393 PMC: 11143989. DOI: 10.2147/NSS.S460989.


Exploring the association between COVID-19 and male genital cancer risk in European population: evidence from mendelian randomization analysis.

Wang D, Ma Y, Yan L, Gan W, Han Y, Tan J BMC Genom Data. 2023; 24(1):56.

PMID: 37749495 PMC: 10521436. DOI: 10.1186/s12863-023-01158-x.


No evidence of a genetic causal relationship between ankylosing spondylitis and iron homeostasis: A two-sample Mendelian randomization study.

Yang M, Yu H, Xu K, Xie J, Zheng H, Feng R Front Nutr. 2023; 10:1047640.

PMID: 37032771 PMC: 10077893. DOI: 10.3389/fnut.2023.1047640.


An inverse causal association between genetically predicted vitamin D and chronic obstructive pulmonary disease risk.

Lu K, Tan J, Li T, Yuan J, Wang H, Wang W Front Nutr. 2023; 10:1111950.

PMID: 37006939 PMC: 10050703. DOI: 10.3389/fnut.2023.1111950.


References
1.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T . Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):811-818. PMC: 7101506. DOI: 10.1001/jamacardio.2020.1017. View

2.
Davey Smith G, Ebrahim S . 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol. 2003; 32(1):1-22. DOI: 10.1093/ije/dyg070. View

3.
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X . 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021; 397(10270):220-232. PMC: 7833295. DOI: 10.1016/S0140-6736(20)32656-8. View

4.
Gage S, Jones H, Burgess S, Bowden J, Davey Smith G, Zammit S . Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study. Psychol Med. 2016; 47(5):971-980. PMC: 5341491. DOI: 10.1017/S0033291716003172. View

5.
Davey Smith G, Hemani G . Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014; 23(R1):R89-98. PMC: 4170722. DOI: 10.1093/hmg/ddu328. View